Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 172

1.

Automated Decellularization of Intact, Human-Sized Lungs for Tissue Engineering.

Price AP, Godin LM, Domek A, Cotter T, D'Cunha J, Taylor DA, Panoskaltsis-Mortari A.

Tissue Eng Part C Methods. 2014 Jun 16. [Epub ahead of print]

PMID:
24826875
[PubMed - as supplied by publisher]
2.

Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans.

Flynn R, Du J, Veenstra RG, Reichenbach DK, Panoskaltsis-Mortari A, Taylor PA, Freeman GJ, Serody JS, Murphy WJ, Munn DH, Sarantopoulos S, Luznik L, Maillard I, Koreth J, Cutler C, Soiffer RJ, Antin JH, Ritz J, Dubovsky JA, Byrd JC, MacDonald KP, Hill GR, Blazar BR.

Blood. 2014 Jun 19;123(25):3988-98. doi: 10.1182/blood-2014-03-562231. Epub 2014 May 12.

PMID:
24820310
[PubMed - in process]
3.

Altered T-cell entry and egress in the absence of Coronin 1A attenuates murine acute graft versus host disease.

Fulton LM, Taylor NA, Coghill JM, West ML, Föger N, Bear JE, Baldwin AS, Panoskaltsis-Mortari A, Serody JS.

Eur J Immunol. 2014 Jun;44(6):1662-71. doi: 10.1002/eji.201344155.

PMID:
24752751
[PubMed - in process]
4.

Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein.

Bachanova V, Cooley S, Defor TE, Verneris MR, Zhang B, McKenna DH, Curtsinger J, Panoskaltsis-Mortari A, Lewis D, Hippen K, McGlave P, Weisdorf DJ, Blazar BR, Miller JS.

Blood. 2014 Jun 19;123(25):3855-63. doi: 10.1182/blood-2013-10-532531. Epub 2014 Apr 9.

PMID:
24719405
[PubMed - in process]
5.

Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality.

Saha A, Aoyama K, Taylor PA, Koehn BH, Veenstra RG, Panoskaltsis-Mortari A, Munn DH, Murphy WJ, Azuma M, Yagita H, Fife BT, Sayegh MH, Najafian N, Socie G, Ahmed R, Freeman GJ, Sharpe AH, Blazar BR.

Blood. 2013 Oct 24;122(17):3062-73. doi: 10.1182/blood-2013-05-500801. Epub 2013 Sep 12.

PMID:
24030385
[PubMed - indexed for MEDLINE]
6.

Club cell secretory protein improves survival in a murine obliterative bronchiolitis model.

Wendt C, Tram K, Price A, England K, Stiehm A, Panoskaltsis-Mortari A.

Am J Physiol Lung Cell Mol Physiol. 2013 Nov 1;305(9):L642-50. doi: 10.1152/ajplung.00021.2013. Epub 2013 Aug 30.

PMID:
23997179
[PubMed - indexed for MEDLINE]
7.

Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration.

Aoyama K, Saha A, Tolar J, Riddle MJ, Veenstra RG, Taylor PA, Blomhoff R, Panoskaltsis-Mortari A, Klebanoff CA, Socié G, Munn DH, Murphy WJ, Serody JS, Fulton LM, Teshima T, Chandraratna RA, Dmitrovsky E, Guo Y, Noelle RJ, Blazar BR.

Blood. 2013 Sep 19;122(12):2125-34. doi: 10.1182/blood-2012-11-470252. Epub 2013 Jun 27.

PMID:
23814022
[PubMed - indexed for MEDLINE]
8.

CC chemokine receptor 8 potentiates donor Treg survival and is critical for the prevention of murine graft-versus-host disease.

Coghill JM, Fowler KA, West ML, Fulton LM, van Deventer H, McKinnon KP, Vincent BG, Lin K, Panoskaltsis-Mortari A, Cook DN, Blazar BR, Serody JS.

Blood. 2013 Aug 1;122(5):825-36. doi: 10.1182/blood-2012-06-435735. Epub 2013 Jun 24.

PMID:
23798714
[PubMed - indexed for MEDLINE]
9.

Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression.

Skubitz AP, Taras EP, Boylan KL, Waldron NN, Oh S, Panoskaltsis-Mortari A, Vallera DA.

Gynecol Oncol. 2013 Sep;130(3):579-87. doi: 10.1016/j.ygyno.2013.05.027. Epub 2013 May 27.

PMID:
23721800
[PubMed - indexed for MEDLINE]
10.

Innate immune function and mortality in critically ill children with influenza: a multicenter study.

Hall MW, Geyer SM, Guo CY, Panoskaltsis-Mortari A, Jouvet P, Ferdinands J, Shay DK, Nateri J, Greathouse K, Sullivan R, Tran T, Keisling S, Randolph AG; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network PICFlu Study Investigators.

Crit Care Med. 2013 Jan;41(1):224-36. doi: 10.1097/CCM.0b013e318267633c.

PMID:
23222256
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine production.

Gleason MK, Verneris MR, Todhunter DA, Zhang B, McCullar V, Zhou SX, Panoskaltsis-Mortari A, Weiner LM, Vallera DA, Miller JS.

Mol Cancer Ther. 2012 Dec;11(12):2674-84. doi: 10.1158/1535-7163.MCT-12-0692. Epub 2012 Oct 17.

PMID:
23075808
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Attenuation of acute graft-versus-host disease in the absence of the transcription factor RORγt.

Fulton LM, Carlson MJ, Coghill JM, Ott LE, West ML, Panoskaltsis-Mortari A, Littman DR, Blazar BR, Serody JS.

J Immunol. 2012 Aug 15;189(4):1765-72. doi: 10.4049/jimmunol.1200858. Epub 2012 Jul 9.

PMID:
22778391
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Distribution of aerosols in murine obliterative bronchiolitis lungs by fluorescent imaging.

Yi D, Wiedmann TS, Naqwi A, Price AP, Panoskaltsis-Mortari A.

Exp Lung Res. 2012 Sep;38(7):325-32. doi: 10.3109/01902148.2012.700760. Epub 2012 Jun 28.

PMID:
22741919
[PubMed - indexed for MEDLINE]
14.

Prolonged subcutaneous administration of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced hematologic malignancies.

Weigel BJ, Cooley S, DeFor T, Weisdorf DJ, Panoskaltsis-Mortari A, Chen W, Blazar BR, Miller JS.

Am J Hematol. 2012 Oct;87(10):953-6. doi: 10.1002/ajh.23280. Epub 2012 Jun 20.

PMID:
22718533
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells.

Veenstra RG, Taylor PA, Zhou Q, Panoskaltsis-Mortari A, Hirashima M, Flynn R, Liu D, Anderson AC, Strom TB, Kuchroo VK, Blazar BR.

Blood. 2012 Jul 19;120(3):682-90. doi: 10.1182/blood-2011-10-387977. Epub 2012 Jun 7.

PMID:
22677125
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The future of tissue-engineered organs for transplant? It's here!

Panoskaltsis-Mortari A.

Semin Thorac Cardiovasc Surg. 2012 Spring;24(1):13-4. doi: 10.1053/j.semtcvs.2012.02.003.

PMID:
22643656
[PubMed - indexed for MEDLINE]
17.

Prevention and mitigation of acute radiation syndrome in mice by synthetic lipopeptide agonists of Toll-like receptor 2 (TLR2).

Shakhov AN, Singh VK, Bone F, Cheney A, Kononov Y, Krasnov P, Bratanova-Toshkova TK, Shakhova VV, Young J, Weil MM, Panoskaltsis-Mortari A, Orschell CM, Baker PS, Gudkov A, Feinstein E.

PLoS One. 2012;7(3):e33044. doi: 10.1371/journal.pone.0033044. Epub 2012 Mar 27.

PMID:
22479357
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Elevated cerebral spinal fluid cytokine levels in boys with cerebral adrenoleukodystrophy correlates with MRI severity.

Lund TC, Stadem PS, Panoskaltsis-Mortari A, Raymond G, Miller WP, Tolar J, Orchard PJ.

PLoS One. 2012;7(2):e32218. doi: 10.1371/journal.pone.0032218. Epub 2012 Feb 16.

PMID:
22359672
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9.

Gleason MK, Lenvik TR, McCullar V, Felices M, O'Brien MS, Cooley SA, Verneris MR, Cichocki F, Holman CJ, Panoskaltsis-Mortari A, Niki T, Hirashima M, Blazar BR, Miller JS.

Blood. 2012 Mar 29;119(13):3064-72. doi: 10.1182/blood-2011-06-360321. Epub 2012 Feb 8.

PMID:
22323453
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Distribution of aerosols in mouse lobes by fluorescent imaging.

Yi D, Naqwi A, Panoskaltsis-Mortari A, Wiedmann TS.

Int J Pharm. 2012 Apr 15;426(1-2):108-15. doi: 10.1016/j.ijpharm.2012.01.037. Epub 2012 Jan 25.

PMID:
22306042
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk